Loring Wolcott & Coolidge Fiduciary Advisors LLP Biogen Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q3 2024

A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Biogen Inc. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 6,479 shares of BIIB stock, worth $971,202. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,479

Previous 6,505 0.4%

Holding current value

$971,202

Previous $1.51 Million 16.72%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$189.07 - $236.8 $4,915 - $6,156	-26 Reduced 0.4%	6,479 $1.26 Million
Q2 2024 Jul 17, 2024	BUY	$190.52 - $236.72 $4,953 - $6,154	26 Added 0.4%	6,505 $1.51 Million
Q4 2023 Feb 01, 2024	SELL	$222.59 - $267.94 $51,195 - $61,626	-230 Reduced 3.43%	6,479 $1.68 Million
Q2 2023 Aug 01, 2023	SELL	$275.25 - $318.06 $48,168 - $55,660	-175 Reduced 2.54%	6,709 $1.91 Million
Q1 2023 May 02, 2023	SELL	$256.56 - $292.34 $51,312 - $58,467	-200 Reduced 2.82%	6,884 $1.91 Million
Q4 2022 Mar 02, 2023	BUY	$252.44 - $306.72 $50,488 - $61,344	200 Added 2.91%	7,084 $1.96 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $94,665 - $115,020	-375 Reduced 5.17%	6,884 $2.01 Million
Q3 2022 Oct 25, 2022	SELL	$194.69 - $268.46 $5,061 - $6,979	-26 Reduced 0.36%	7,259 $1.94 Million
Q2 2022 Jul 26, 2022	BUY	$187.54 - $223.02 $4,876 - $5,798	26 Added 0.36%	7,285 $1.49 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $89,568 - $115,108	-400 Reduced 5.22%	7,259 $1.74 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $21,224 - $27,678	-75 Reduced 0.97%	7,659 $2.17 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $121,212 - $194,084	-468 Reduced 5.71%	7,734 $2.68 Million
Q1 2021 Apr 14, 2021	SELL	$242.95 - $284.63 $20,893 - $24,478	-86 Reduced 1.04%	8,202 $2.3 Million
Q4 2020 Jan 14, 2021	BUY	$236.26 - $355.63 $945 - $1,422	4 Added 0.05%	8,288 $2.03 Million
Q4 2019 Jan 22, 2020	SELL	$220.06 - $304.07 $2,420 - $3,344	-11 Reduced 0.13%	8,284 $2.46 Million
Q3 2019 Nov 05, 2019	SELL	$217.44 - $243.88 $10,872 - $12,194	-50 Reduced 0.6%	8,295 $1.93 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $6,140 - $6,768	-28 Reduced 0.33%	8,345 $1.95 Million
Q1 2019 Apr 08, 2019	SELL	$216.71 - $338.96 $11,702 - $18,303	-54 Reduced 0.64%	8,373 $1.98 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $15,039 - $19,048	54 Added 0.64%	8,427 $2.54 Million
Q3 2018 Oct 31, 2018	SELL	$293.51 - $383.83 $29,351 - $38,383	-100 Reduced 1.18%	8,373 $2.96 Million
Q1 2018 Apr 20, 2018	SELL	$260.13 - $367.91 $13,006 - $18,395	-50 Reduced 0.59%	8,473 $2.32 Million
Q3 2017 Oct 27, 2017	BUY	$281.15 - $329.69 $3,092 - $3,626	11 Added 0.13%	8,523 $2.67 Million
Q2 2017 Aug 07, 2017	BUY	N/A	8,512	8,512 $0

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account

Loring Wolcott & Coolidge Fiduciary Advisors LLP Biogen Inc. Transaction History